ReviewLung Cancer (Auckland, N.Z.)2022

A Long Overdue Targeted Treatment for KRAS Mutations in NSCLC: Spotlight on Adagrasib.

Danielle Brazel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.